# Use of Progenitor Biological Bandages in Burn Care (Bru_PBB)

> **NCT05339490** · PHASE1,PHASE2 · TERMINATED · sponsor: **Dr Anthony De Buys Roessingh** · enrollment: 76 (actual)

## Conditions studied

- Burn Injury

## Interventions

- **DRUG:** Progenitor Biological Bandages
- **DEVICE:** Jelonet

## Key facts

- **NCT ID:** NCT05339490
- **Lead sponsor:** Dr Anthony De Buys Roessingh
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-07-01
- **Primary completion:** 2025-07-17
- **Final completion:** 2025-07-17
- **Target enrollment:** 76 (ACTUAL)
- **Why stopped:** Following issues with the quality of the clinical cell banks used to manufacture the biological dressings, we decided not to implement this research to not compromise neither the patient safety, nor the expected efficacy of the treatment.
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05339490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05339490, "Use of Progenitor Biological Bandages in Burn Care (Bru_PBB)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05339490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*